Use of Circulating Tumor Cell Technology recognized by Cleveland Clinic as #1 Top Medical Innovation for 2009. Immunicon’s new technology to measure circulating tumor cells (CTCs) in a sample of blood to aid in the early detection of rogue cancer cells in patients with recurrent cancer.  For more information, visit: http://www.clevelandclinic.org/innovations/summit/topten09/one.html